Feedback
The current prices are delayed. Login to see live prices.

Glenmark Pharmaceuticals Ltd.

(GLENMARK)

10123456789,401234567893012345678980123456789.4012345678900123456789
+13.80 (+0.97%)
Updated 15:56 26/07 IST
Add
1D
5D
1M
3M
1Y
5Y
MAX
Previous Close: 1424.6
Today's low
โ‚น1,420.10
Today's high
โ‚น1,454.2
52 week low
โ‚น722.1
52 week high
โ‚น1,454.2
Open
โ‚น1,423
Prev Close
โ‚น1,424.6
Volume (shares)
703,609
Total Trading Value
100.24 Cr

Technicals

SMA
Value
Signal
12-SMA
1,411.23
Bullish
20-SMA
1,365.62
Bullish
50-SMA
1,241.22
Bullish
100-SMA
1,118.17
Bullish
200-SMA
972.26
Bullish

Valuations

PE Chart
102030405060
Median PE (M) : 25.89
Current PE is lower than median PE.
PB Chart
3.03.54.04.55.0
Median PB (M) : 3.16
Current PB is higher than median PB.

Fundamentals

Market Cap
โ‚น40,591.65 Cr
Enterprise Value
โ‚น43,469.67 Cr
No. of Shares
28.22 Cr
P/E Ratio(TTM)
0
RoE
4.07%
Debt/Equity
0.46
Revenue vs Profitability (In Cr.)
2468101214
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Revenue
Profit
Margins (%)
5101520
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Gross Margin
Net Margin

Ratios

Debt/Equity
0.400.500.600.700.80
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
Debt to Equity
ROE vs ROCE
46810121416
Mar, 2020Mar, 2021Mar, 2022Mar, 2023
ROE
ROCE

Shareholding

Shareholding Pattern
Public : 18.41%
FII : 20.98%
Others : 0%
DII : 13.96%
Promoter : 46.65%
Shareholding History
21.022.023.024.025.0
Mar, 2023Jun, 2023Sep, 2023Dec, 2023Mar, 2024Jun, 2024

Peer Comparison

Peer companies
Market Capital (Cr.)
P/E
P/B
Price(โ‚น)
SUNPHARMA
411,150.04
42.95
17.36
1,665.8
ABBOTINDIA
60,853.54
0
16.6
28,012.5
GLAXO
45,898.02
77.74
25.58
2,677.85
BIOCON
44,254.12
43.27
4.08
361.85
GLENMARK
40,501.06
0
1.77
1,424.6
GLAND
33,282.32
43.01
3.69
2,004.95
IPCALAB
32,588.31
59.58
5.14
1,258.55

Discussions

ย ย โ€ขย ย Jul 18 3:28 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Glenmark Pharmaceuticals share price touched a 52-week...read more

1

ย ย โ€ขย ย Jul 18 4:46 AM
Glenmark Pharmaceuticals gets final approval for Topiramate Capsules
News Summary...read more

ย ย โ€ขย ย Jul 17 4:13 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Glenmark Pharmaceuticals Ltd. has received final appro...read more

2
ย ย โ€ขย ย Jul 17 3:43 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Glenmark Pharmaceuticals has received final approval f...read more

ย ย โ€ขย ย Jul 11 3:38 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Glenmark Pharma will completely exit Glenmark Life Sci...read more

1

1
ย ย โ€ขย ย Jul 11 2:31 AM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Promoters of Glenmark Life Sciences Ltd. will divest u...read more

2

ย ย โ€ขย ย Jul 6 12:20 AM
Weekly Update:
Last week I have shared 3 stocks: ...read more

1

ย ย โ€ขย ย Jun 30 1:11 PM
#GLENMARK : POSITIONAL TRADE SETUP
FUNDAMENTAL:...read more

11

6
ย ย โ€ขย ย Jun 24 1:54 AM
BUY ABOVE 1260...read more

1
ย ย โ€ขย ย Jun 21 1:24 AM
TRADE ON BREAKOUT SIDE

14

3
17
ย ย โ€ขย ย Jun 20 10:58 PM
#Breakout

1
ย ย โ€ขย ย Jun 19 6:16 AM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข An expert committee is set to discuss the feasibility ...read more

ย ย โ€ขย ย Jun 18 5:24 PM
BUY GLENMARK 1260 CE 20-22 SL 16 TGT 29-35...read more

1

ย ย โ€ขย ย Jun 13 8:33 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข KR Choksey has recommended a buy rating on Glenmark Ph...read more

ย ย โ€ขย ย Jun 13 4:46 AM
Glenmarkโ€™s arm gets USFDAโ€™s approval for Esomeprazole Magnesium Delayed-Release Capsules...read more

1
ย ย โ€ขย ย Jun 12 5:03 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Glenmark Specialty SA has received final approval from...read more

ย ย โ€ขย ย Jun 11 11:08 PM
๐—ก๐—ฒ๐˜„๐˜€ ๐—ฆ๐˜‚๐—บ๐—บ๐—ฎ๐—ฟ๐˜†
โ€ข Motilal Oswal has given a Neutral rating on Glenmark P...read more

ย ย โ€ขย ย Jun 10 4:13 PM
๐Ÿšจ๐Ÿšจ๐ŸšจSTOCK OPTION ๐Ÿšจ๐Ÿšจ๐Ÿšจ
....read more

Load More Posts

Frequently Asked Questions (FAQs)

What is the Share Price of Glenmark Pharmaceuticals Ltd. ?

The share prices are volatile and fluctuate throughout the trading hours. The share price of Glenmark Pharmaceuticals Ltd. is Rs 1424.6 as of 26 July 2024.

What is the Market Capitalization of Glenmark Pharmaceuticals Ltd. ?

The current market cap of Glenmark Pharmaceuticals Ltd. is โ‚น40591.65 Cr. Market capitalisation is calculated by multiplying the current share price with the total number of shares.

What are the PE and PB ratios of Glenmark Pharmaceuticals Ltd.?

Glenmark Pharmaceuticals Ltd. has a price-to-earnings (PE) ratio of 0 and a price-to-book (PB) ratio of 5.17.

What is the 52-week high/low of Glenmark Pharmaceuticals Ltd.?

The 52-week high of Glenmark Pharmaceuticals Ltd. is Rs 1454.2 and the 52-week low is Rs 722.1
Hero Img
Join 10,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
Create your account on Frontpage
Disclaimerโ€ขPrivacyโ€ขโ€ข
FrontPage ยฉ 2024